Search

Despite many attempts to build g‐C3N4 based heterojunctions there are currently no systematic guidelines for designing such composites. Herein, we rationally designed and synthesized a novel CaSb2O6/g‐C3N4 2D/2D heterojunction with ideal lattice matching. The as‐synthesized heterojunctions had superior visible light‐driven photodegradation toward tetracycline solution compared with those of pristine g‐C3N4 and CaSb2O6. The corresponding maximum apparent kinetic rate constant was 0.01388 min–1, which was approximately 2.4 and 53 times greater than those of g‐C3N4 and CaSb2O6, respectively. Additionally, photoelectrochemical measurements indicated that the enhanced photocatalytic performance was attributed to generation of an internal electric field by the intimate contact p‐n heterojunction. The main reactive species were ·OH, ·O2– and h– are the dominate reactive species in the photocatalytic process. This study will inspire efforts to build 2D/2D heterojunction photocatalysts with efficient carrier separation and higher photocatalytic performance through structural chemistry or solid state chemistry analysis. [ABSTRACT FROM AUTHOR]

Rhenium disulfide (ReS 2 ) is a promising piezoelectric catalyst due to its excellent electron transfer ability and abundant unsaturated sites. The 1T' phase structure leads to the evolution of ReS 2 into a centrosymmetric spatial structure, which restricts its application in piezoelectric catalysis. Herein, we propose a controllable defect engineering strategy to trigger the piezoelectric response of ReS 2 . The introduction of vacancy defects disrupts the initial centrosymmetric structure, which breaks the piezoelectric polarization bond and generates piezoelectric properties. By using transmission electron microscopy, we characterized it at the atomic scale and determined that vacancy defects contribute to an excellent piezoelectric property through first-principles calculations. Notably, the piezoelectric coefficient of the catalyst with 40 s-etching (ReS 2 @C-40) is 23.07 pm/V, an order of magnitude greater than other transition metal dichalcogenides. It demonstrated the feasibility of optimizing piezoelectric properties by increasing the conformational asymmetry. Based on its remarkable piezoelectric activity, ReS 2 @C-40 exhibits highly efficient piezo-photocatalytic synergistic sterilization performance with 99.99% eradication of Escherichia coli and 96.67% of Staphylococcus aureus within 30 min. This pioneering research on the coupling effect of ReS 2 in piezoelectric catalysis and photocatalysis provides ideas for the development of piezo-photocatalysts and efficient water purification technologies.

Objectives: To analyze the clinical characteristics and prognosis of children with anti-N-methyl- D -aspartate receptor (NMDAR) encephalitis and to provide a basis for early clinical identification of this disease., Methods: The clinical data of 42 cases of anti-NMDAR encephalitis at Department of Pediatrics, Second Xiangya Hospital, Central South University from January 2015 to March 2018 were collected. The clinical features and followed-up outcomes were analyzed retrospectively., Results: There were 15 cases (35.7%) of males and 27 cases (64.3%) of females in 42 children, with a ratio of 1꞉1.8. They were aged from 4 months to 17 years, with an average of (9.20±4.66) years. The most common initial symptoms were seizures (47.6%, 20/42) and mental behavior disorder (35.7%, 15/42). During the course of the disease, 85.7% patients(36/42) had mental and behavior disorder, 85.7% patients (36/42) had epilepsy, 76.2% (32/42) had speech disorder, 66.7% patients (28/42) had dyskinesia, 66.7% patients (28/42) had the decreased level of consciousness, 61.9% patients (26/42) had autonomic instability, and 57.1% (24/42) patients had sleep disorder. All the children had positive antibody against NMDA receptor resistance encephalitis in cerebrospinal fluid. Head MRI showed the abnormal incidence was 50.0% (21/42), and the lesions involved in parietal lobe, frontal lobe, temporal lobe, occipital lobe, midbrain, thalamus, basal ganglia and optic nerve. There was a patient with optic nerve damage combined with myelin oligodendrocyte glycoprotein (MOG) antibody positive. Forty cases were examined by electroencephalogram (EEG), 92.5% cases (37/40) were abnormal, mainly showing diffuse slow waves, and δ brushes could be seen in severe cases. And there was 1 patient (2.4%) complicated with mesenteric teratoma. The mRS score (2.14±1.46) at discharge was significantly lower than the highest mRS score (3.88±1.38) during hospitalization ( P <0.05). After 3-39 months of follow-up, mRS score at 3 months after discharge was only 0.81±1.29, which was still improved compared with that at discharge, 76.2% cases (32/42) experienced complete or near-complete recovery (mRS score≤2), and 4.8% (2/42) cases relapsed. There was no mortality; the initial time of immunotherapy and the highest mRS score in the course of the disease were the factors affecting the prognosis. The earlier the starting time for immunotherapy and the lower mRS score in the course of the disease were, the better the prognosis was., Conclusions: Seizures, mental and behavior disorder, dyskinesias, speech disorder and autonomic instability are common clinical manifestations of anti-NMDAR encephalitis in children. The effect of immunotherapy is significant, and the time to start immunotherapy and the severity of the disease are important factors affecting the prognosis. Anti-NMDAR encephalitis can be combined with other autoantibodies, but its clinical significance and mechanism need further study.

p53 and p63 share extensive sequence and structure homology. p53 is frequently mutated in cancer, whereas mutations in p63 cause developmental disorders manifested in ectodermal dysplasia, limb defects, and orofacial clefting. We have established primary adult skin keratinocytes from ectrodactyly, ectodermal dysplasia, and cleft lip/palate (EEC) syndrome patients with p63 mutations as an in vitro human model to study the disease mechanism in the skin of EEC patients. We show that these patient keratinocytes cultured either in submerged 2D cultures or in 3D skin equivalents have impaired epidermal differentiation and stratification. Treatment of these patient keratinocytes with the mutant p53-targeting compound APR-246/PRIMA-1(MET) (p53 reactivation and induction of massive apoptosis) that has been successfully tested in a phase I/II clinical trial in cancer patients partially but consistently rescued morphological features and gene expression during epidermal stratification in both 2D and 3D models. This rescue coincides with restoration of p63 target-gene expression. Our data show that EEC patient keratinocytes with p63 mutations can be used for characterization of the abnormal molecular circuitry in patient skin and may open possibilities for the design of novel pharmacological treatment strategies for patients with mutant p63-associated developmental abnormalities.